{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:16:21Z","timestamp":1790144181531,"version":"4.0.1"},"reference-count":160,"publisher":"Elsevier","isbn-type":[{"value":"9780444642561","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.pbr.2019.10.004","type":"book-chapter","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T08:53:12Z","timestamp":1575017592000},"page":"181-208","source":"Crossref","is-referenced-by-count":4,"title":["Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pbr.2019.10.004_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2017.05.002","article-title":"Age exacerbates abnormal protein expression in a mouse model of Down syndrome","volume":"57","author":"Ahmed","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/bs.pbr.2019.10.004_bb0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/jnnp.49.8.886","article-title":"Isolated senile plaque cores in Alzheimer's disease and Down's syndrome show differences in morphology","volume":"49","author":"Allsop","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","article-title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","volume":"12","author":"Annus","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5114\/fn.2012.30524","article-title":"Size frequency distributions of \u03b2-amyloid (A\u03b2) deposits: a comparative study of four neurodegenerative disorders","volume":"50","author":"Armstrong","year":"2012","journal-title":"Folia Neuropathol."},{"issue":"3 Pt 1","key":"10.1016\/bs.pbr.2019.10.004_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"41","key":"10.1016\/bs.pbr.2019.10.004_bb0035","article-title":"Down syndrome: An insight of the disease","volume":"22","author":"Asim","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/bs.pbr.2019.10.004_bb0040","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/jamaneurol.2018.2210","article-title":"Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome","volume":"75","author":"Bayen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/bs.pbr.2019.10.004_bb0045","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archpsyc.62.12.1360","article-title":"Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study","volume":"62","author":"Beacher","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152471","article-title":"An anti-\u03b2-amyloid vaccine for treating cognitive deficits in a mouse model of Down syndrome","volume":"11","author":"Belichenko","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0060","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"1","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuroscience.2017.12.038","article-title":"The GABA a \u03b15-selective modulator, RO4938581, rescues protein anomalies in the Ts65Dn mouse model of Down syndrome","volume":"372","author":"Block","year":"2018","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/bs.pbr.2019.10.004_bb0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2010.05.007","article-title":"Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system","volume":"12","author":"Bloemers","year":"2010","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.1996.tb05866.x","article-title":"Evolution of the neuropathology of Alzheimer's disease","volume":"165","author":"Braak","year":"1996","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"Pt B","key":"10.1016\/bs.pbr.2019.10.004_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brainres.2015.08.031","article-title":"How microglia kill neurons","volume":"1628","author":"Brown","year":"2015","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0095","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.410180306","article-title":"Abnormalities of the nucleus basalis in Down's syndrome","volume":"18","author":"Casanova","year":"1985","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/bs.pbr.2019.10.004_bb0110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","article-title":"A\u03b2 localization in abnormal endosomes: association with earliest A\u03b2 elevations in AD and Down syndrome","volume":"25","author":"Cataldo","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"17","key":"10.1016\/bs.pbr.2019.10.004_bb0115","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1523\/JNEUROSCI.23-17-06788.2003","article-title":"App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome","volume":"23","author":"Cataldo","year":"2003","journal-title":"J Neurosci."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnbeh.2015.00330","article-title":"Principal component analysis of the effects of environmental enrichment and (\u2212)-epigallocatechin-3-gallate on age-associated learning deficits in a mouse model of Down syndrome","volume":"9","author":"Catuara-Solarz","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/bs.pbr.2019.10.004_bb9000","first-page":"644849","article-title":"Altered hippocampal-prefrontal neural dynamics in mouse models of down syndrome","author":"Chang","year":"2019"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fnins.2019.00659","article-title":"Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0130","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1038\/ncomms5430","article-title":"Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells","volume":"5","author":"Chen","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00726-007-0618-9","article-title":"Protein expression of BACE1, BACE2 and APP in Down syndrome brains","volume":"35","author":"Cheon","year":"2008","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0140","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1471-4159.2009.06277.x","article-title":"Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model","volume":"110","author":"Choi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fnbeh.2015.00268","article-title":"Dissecting Alzheimer disease in Down syndrome using mouse models","volume":"9","author":"Choong","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.2006.03769.x","article-title":"Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases","volume":"97","author":"Contestabile","year":"2006","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/bs.pbr.2019.10.004_bb0155","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1073\/pnas.181219298","article-title":"Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion","volume":"98","author":"Cooper","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/bs.pbr.2019.10.004_bb0160","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/hmg\/dds142","article-title":"Trisomy for Synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes","volume":"21","author":"Cossec","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0165","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist Memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/bs.pbr.2019.10.004_bb0170","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.18632\/oncotarget.23738","article-title":"The genes associated with early-onset Alzheimer's disease","volume":"9","author":"Dai","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2013.05.024","article-title":"Formoterol, a long-acting \u03b22 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome","volume":"75","author":"Dang","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","article-title":"The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome","volume":"6","author":"Davidson","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0185","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down syndrome","volume":"384","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Biol. Res."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000472398","article-title":"Molecular mapping of twenty-four features of Down syndrome on chromosome 21","volume":"1","author":"Delabar","year":"1993","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of Alzheimer's disease: the role of APP HHS Public Access","volume":"56","author":"Doran","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2016.06.010","article-title":"Increases of SET level and translocation are correlated with tau hyperphosphorylation at ser202\/thr205 in CA1 of Ts65Dn mice","volume":"46","author":"Dorard","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"11\u221212","key":"10.1016\/bs.pbr.2019.10.004_bb0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","article-title":"Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome","volume":"22","author":"Duchon","year":"2011","journal-title":"Mamm. Genome"},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cvr\/cvq193","article-title":"Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse","volume":"88","author":"Dunlevy","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fnagi.2018.00263","article-title":"Rapamycin treatment ameliorates age-related accumulation of toxic metabolic intermediates in brains of the Ts65Dn mouse model of Down syndrome and aging","volume":"10","author":"Duval","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","article-title":"Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of \u03b21-adrenergic receptor by xamoterol as a potential cognitive enhancer","volume":"43","author":"Faizi","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/acn3.571","article-title":"Aging related cognitive changes associated with Alzheimer's disease in Down syndrome","volume":"5","author":"Firth","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.2658-14.2015","article-title":"Designer receptors enhance memory in a mouse model of Down syndrome","volume":"35","author":"Fortress","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes","volume":"106","author":"Garc\u00eda-Cerro","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0240","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0245","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1034\/j.1399-0004.2002.620506.x","article-title":"The changing survival profile of people with Down's syndrome: implications for genetic counselling","volume":"62","author":"Glasson","year":"2002","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/bs.pbr.2019.10.004_bb0250","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/adc.2003.046219","article-title":"Cancers and immune related diseases associated with Down's syndrome: a record linkage study","volume":"89","author":"Goldacre","year":"2004","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0260","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/exnr.1999.7289","article-title":"Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome","volume":"161","author":"Granholm","year":"2000","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0265","doi-asserted-by":"crossref","first-page":"e60482","DOI":"10.1371\/journal.pone.0060482","article-title":"Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome","volume":"8","author":"Gribble","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0270","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s13311-014-0295-9","article-title":"Genetics of Alzheimer's disease","volume":"11","author":"Guerreiro","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","article-title":"Intraneuronal A\u03b2-amyloid precedes development of amyloid plaques in Down syndrome","volume":"125","author":"Gyure","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-017-0499-4","article-title":"Cerebrovascular pathology in Down syndrome and Alzheimer disease","volume":"5","author":"Head","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0290","doi-asserted-by":"crossref","first-page":"e0195771","DOI":"10.1371\/journal.pone.0195771","article-title":"High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development","volume":"13","author":"Hefti","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0295","first-page":"1","article-title":"Microbleeds and cerebral amyloid Angiopathy in the brains of people with Down syndrome with Alzheimer's disease","author":"Helman","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/bs.pbr.2019.10.004_bb0300","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0387-7604(02)00209-7","article-title":"Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome","volume":"25","author":"Hirayama","year":"2003","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0310","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1073\/pnas.89.4.1383","article-title":"Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants","volume":"89","author":"Holtzman","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"23","key":"10.1016\/bs.pbr.2019.10.004_bb0315","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6286","key":"10.1016\/bs.pbr.2019.10.004_bb0320","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"45","key":"10.1016\/bs.pbr.2019.10.004_bb9005","doi-asserted-by":"crossref","first-page":"18530","DOI":"10.1074\/jbc.M117.808121","article-title":"Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade","volume":"292","author":"Huffaker","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-0102(03)00005-1","article-title":"Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome","volume":"45","author":"Hunter","year":"2003","journal-title":"Neurosci. Res."},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0330","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neurobiolaging.2003.10.010","article-title":"Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen","volume":"25","author":"Hunter","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbi.2018.10.004","article-title":"Restoring microglial and astroglial homeostasis using DNA immunization in a Down syndrome mouse model","volume":"75","author":"Illouz","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0340","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","article-title":"Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome","volume":"37","author":"Iwatsubo","year":"1995","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0345","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0350","article-title":"Alzheimer's-related endosome dysfunction in Down syndrome is A\u03b2-independent but requires APP and is reversed by BACE-1 inhibition","author":"Jiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0355","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurobiolaging.2015.11.013","article-title":"Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF HHS Public Access","volume":"39","author":"Jiang","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0360","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20180653","article-title":"Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau","volume":"215","author":"Kang","year":"2018","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0365","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0370","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3727\/096368910X528085","article-title":"Neural stem cells reduce hippocampal tau and Reelin accumulation in aged Ts65Dn Down syndrome mice","volume":"20","author":"Kern","year":"2011","journal-title":"Cell Transplant."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0375","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/mp.2015.97","article-title":"Evidence that the rab5 effector APPL1 mediates APP-\u03b2CTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease","volume":"21","author":"Kim","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/bs.pbr.2019.10.004_bb0380","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1073\/pnas.91.11.4997","article-title":"Down syndrome phenotypes: the consequences of chromosomal imbalance","volume":"91","author":"Korenberg","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0385","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11614","article-title":"Genetic dissection of Down syndrome- associated congenital heart defects using a new mouse mapping panel","volume":"5","author":"Lana-Elola","year":"2016","journal-title":"Elife"},{"issue":"8","key":"10.1016\/bs.pbr.2019.10.004_bb0390","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb9015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0395","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3233\/JAD-140207","article-title":"Region-specific expression of tau, amyloid-\u03b2 protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats\u2019","volume":"41","author":"Lin","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0400","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nicl.2016.06.001","article-title":"1 H-MRS metabolites in adults with Down syndrome: effects of dementia","volume":"11","author":"Lin","year":"2016","journal-title":"NeuroImage"},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0405","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"Faseb J."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011546","article-title":"Pharmacological interventions for cognitive decline in people with Down syndrome","volume":"10","author":"Livingstone","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0415","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbr.2010.03.036","article-title":"Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome","volume":"221","author":"Lockrow","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0420","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2009.08.052","article-title":"\u03b2-Amyloid overload does not directly correlate with SAPK\/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice","volume":"1297","author":"Lomoio","year":"2009","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0425","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","article-title":"Alzheimer's disease and Down's syndrome","volume":"13","author":"Mann","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0430","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","article-title":"The pathological association between Down syndrome and Alzheimer disease","volume":"43","author":"Mann","year":"1988","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0435","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2990.1984.tb00351.x","article-title":"Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes","volume":"10","author":"Mann","year":"1984","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0440","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-018-1866-3","article-title":"Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease","volume":"136","author":"Mann","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0445","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.65.3.405","article-title":"A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors","author":"McCarron","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0450","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2014","journal-title":"J. Intellect. Disabil. Res."},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0455","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/jir.12390","article-title":"A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"61","author":"McCarron","year":"2017","journal-title":"J. Intellect. Disabil. Res."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/ijmr.IJMR_473_17","article-title":"New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies","volume":"148","author":"Misra","year":"2018","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0465","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/13506120208995241","article-title":"Intraneuronal Abeta42 accumulation in Down syndrome brain","volume":"9","author":"Mori","year":"2002","journal-title":"Amyloid: Int. J. Experiment. Clin. Investig."},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0470","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1101\/lm.969608","article-title":"Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome","volume":"15","author":"Morice","year":"2008","journal-title":"Learn. Mem."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0269881117743484","article-title":"In vivo and ex vivo analyses of amyloid toxicity in the Tc1 mouse model of Down syndrome","volume":"32","author":"Naert","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0480","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13506120802524981","article-title":"Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome","volume":"15","author":"Naito","year":"2008","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010943","article-title":"Lowering \u03b2-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model","volume":"5","author":"Netzer","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0490","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035634","article-title":"Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A","volume":"11","author":"Nguyen","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"10","key":"10.1016\/bs.pbr.2019.10.004_bb0495","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain","volume":"28","author":"Nistor","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0500","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease","author":"Nixon","year":"2018","journal-title":"Faseb J."},{"issue":"5743","key":"10.1016\/bs.pbr.2019.10.004_bb0505","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1126\/science.1114535","article-title":"An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes","volume":"309","author":"O'Doherty","year":"2005","journal-title":"Science (New York, N.Y.)"},{"issue":"5696","key":"10.1016\/bs.pbr.2019.10.004_bb0510","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1098992","article-title":"A chromosome 21 critical region does not cause specific Down syndrome phenotypes","volume":"306","author":"Olson","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0515","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1046\/j.1471-4159.1994.62031062.x","article-title":"Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination","volume":"62","author":"Oyama","year":"1994","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/bs.pbr.2019.10.004_bb0520","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0525","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down's syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/bs.pbr.2019.10.004_bb0530","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3233\/JAD-130824","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) enhances tau expression","volume":"37","author":"Qian","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0535","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamaneurol.2016.5953","article-title":"Neurofibrillary tangle stage and the rate of progression of Alzheimer symptoms","volume":"74","author":"Qian","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0540","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/dneu.22658","article-title":"Tau PET imaging for staging of Alzheimer's disease in Down syndrome","volume":"79","author":"Rafii","year":"2018","journal-title":"Dev. Neurobiol."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0545","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-170390","article-title":"PET imaging of tau pathology and relationship to amyloid, longitudinal MRI, and cognitive change in down syndrome: results from the down syndrome biomarker initiative (DSBI)","volume":"60","author":"Rafii","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"6558","key":"10.1016\/bs.pbr.2019.10.004_bb0555","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/378720a0","article-title":"Chromosome engineering in mice","volume":"378","author":"Ramirez-Solis","year":"1995","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.pbr.2019.10.004_bb0560","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2174\/1567205012666150701103107","article-title":"Neurobiology of Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions","volume":"12","author":"Raskin","year":"2015","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0565","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"issue":"11\u201312","key":"10.1016\/bs.pbr.2019.10.004_bb9025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"issue":"6423","key":"10.1016\/bs.pbr.2019.10.004_bb0570","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-\u03b2 precursor protein functions as a GABA B R1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0575","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/bs.pbr.2019.10.004_bb0580","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/jnnp.2006.113514","article-title":"APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage","volume":"78","author":"Rovelet-Lecrux","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0585","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0590","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2010-100240","article-title":"Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome","volume":"21","author":"Rueda","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0595","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbi.2018.05.008","article-title":"Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice","volume":"73","author":"Rueda","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"22","key":"10.1016\/bs.pbr.2019.10.004_bb0600","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","article-title":"Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease","volume":"320","author":"Rumble","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/bs.pbr.2019.10.004_bb0605","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.95.11.6256","article-title":"Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities","volume":"95","author":"Sago","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0610","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/bs.pbr.2019.10.004_bb0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"Pt. A","key":"10.1016\/bs.pbr.2019.10.004_bb0620","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2016.06.006","article-title":"Experience-dependent reduction of soluble \u03b2-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome","volume":"283","author":"Sansevero","year":"2016","journal-title":"Exp. Neurol."},{"issue":"17","key":"10.1016\/bs.pbr.2019.10.004_bb0625","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer's disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"Embo J."},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0630","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0635","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.expneurol.2004.11.017","article-title":"Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice","volume":"193","author":"Seo","year":"2005","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0640","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.06.025","article-title":"Altered regulation of tau phosphorylation in a mouse model of down syndrome aging","volume":"33","author":"Sheppard","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"18","key":"10.1016\/bs.pbr.2019.10.004_bb0650","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddl211","article-title":"Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome","volume":"15","author":"Shukkur","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0655","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/srep00137","article-title":"Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome","volume":"1","author":"Simoes de Souza","year":"2011","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0660","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-170624","article-title":"Predictors of age of diagnosis and survival of Alzheimer's disease in Down syndrome","volume":"61","author":"Sinai","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0665","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awl203","article-title":"APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy","volume":"129","author":"Sleegers","year":"2006","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0670","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2017.03.012","article-title":"Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome","volume":"103","author":"Stagni","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0675","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jalz.2018.08.009","article-title":"Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome","volume":"15","author":"Startin","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0680","first-page":"703","article-title":"Alzheimer's disease in Down syndrome: an overlooked population for prevention trials","volume":"4","author":"Strydom","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0685","doi-asserted-by":"crossref","first-page":"14818","DOI":"10.1038\/s41598-017-13858-3","article-title":"Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation","volume":"7","author":"Sullivan","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0690","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0695","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/appi.ajp.160.4.646","article-title":"The genes and brains of mice and men","volume":"160","author":"Tecott","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"44","key":"10.1016\/bs.pbr.2019.10.004_bb0700","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0705","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-018-0133-9","article-title":"Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome","volume":"7","author":"Tramutola","year":"2018","journal-title":"Transl. Neurodegeneration"},{"issue":"Suppl 2","key":"10.1016\/bs.pbr.2019.10.004_bb0710","article-title":"New techniques to understand chromosome dosage: mouse models of aneuploidy","volume":"15","author":"Tybulewicz","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0715","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jir.12196","article-title":"Risk factors for mortality in Down syndrome","volume":"59","author":"Uppal","year":"2015","journal-title":"J. Intellect. Disabil. Res."},{"issue":"6","key":"10.1016\/bs.pbr.2019.10.004_bb0720","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.tibs.2015.03.011","article-title":"Gene dosage imbalances: action, reaction, and models","volume":"40","author":"Veitia","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/bs.pbr.2019.10.004_bb0725","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00335-004-2428-7","article-title":"Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12","volume":"16","author":"Villar","year":"2005","journal-title":"Mamm. Genome"},{"key":"10.1016\/bs.pbr.2019.10.004_bb0730","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnmol.2017.00043","article-title":"APP-A Novel Player within the Presynaptic Active Zone Proteome","volume":"10","author":"Weingarten","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0735","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","article-title":"Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease","volume":"36","author":"Wilcock","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch. Neurol."},{"issue":"R1","key":"10.1016\/bs.pbr.2019.10.004_bb0745","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1093\/hmg\/ddp010","article-title":"Down syndrome\u2014recent progress and future prospects","volume":"18","author":"Wiseman","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0750","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/bs.pbr.2019.10.004_bb0755","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/brain\/awy159","article-title":"Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of APP","volume":"141","author":"Wiseman","year":"2018","journal-title":"Brain"},{"issue":"9","key":"10.1016\/bs.pbr.2019.10.004_bb0760","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","article-title":"The population prevalence of Down's syndrome in England and Wales in 2011","volume":"21","author":"Wu","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/bs.pbr.2019.10.004_bb0765","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","article-title":"Amyloid precursor protein\u2013mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/bs.pbr.2019.10.004_bb0770","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41598-017-00682-y","article-title":"Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice","volume":"7","author":"Yin","year":"2017","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/bs.pbr.2019.10.004_bb0775","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/bs.pbr.2019.10.004_bb0780","first-page":"4120","article-title":"Whether Alzheimer's diseases related genes also differently express in the hippocampus of Ts65Dn mice?","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/bs.pbr.2019.10.004_bb0785","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0074-7750(08)00004-9","article-title":"Alzheimer's disease in adults with Down syndrome","volume":"36","author":"Zigman","year":"2008","journal-title":"Int. Rev. Res. Ment. Retard."}],"container-title":["Progress in Brain Research","Preclinical Research in Down Syndrome: Insights for Pathophysiology and Treatments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319302018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612319302018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:02:02Z","timestamp":1758751322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612319302018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780444642561"],"references-count":160,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2019.10.004","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}